Skip to main content
Log in

Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins

  • Original Articles
  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Abstract

The effects of prostaglandin E2 (PGE2), 15-methyl prostaglandin E2 (15M), and 16,16-dimethyl prostaglandin E2 (16DM) on gastric mucus and nonparietal cell secretion in rats were measured. Alcian blue binding was used as a measure of gastric mucus. Applied topically, all three agents stimulated nonparietal cell secretion, and PGE2 and 16 DM stimulated the secretion of mucus, increasing the fraction in the gastric contents but not that adherent to the mucosa. Topical 15M did not stimulate the production of mucus. Given intravenously, all three agents increased the amount of mucus in the gastric contents without altering the amount of mucus bound to the mucosa. The prostaglandins had no effect on nonparietal cell secretion when given intravenously. These effects could be relevant to the ability of the E2 prostaglandins to protect the gastric mucosa from damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Robert A, Schultz JR, Nezamis JE, Lancaster C: Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2 and 16,16-dimethyl PGE2. Intravenous, oral and intrajejunal administration. Gastroenterology 70:259–270, 1976

    Google Scholar 

  2. Robert A, Magerlein BJ: 15-methyl PGE2 and 16,16-dimethyl PGE2: Potent inhibitors of gastric secretion. Adv Biosci 9:247–253, 1973

    Google Scholar 

  3. Karim SMM, Carter DC, Bhana D, Adaikan Ganesan P: Effect of orally administered prostaglandin E2 and its 15-methyl analogues on gastric secretion. Br Med J 1:142–146, 1973

    Google Scholar 

  4. Wada T, Ishizawa M: Effect of prostaglandin on the function of gastric secretion (in Japanese). Nippon Rinsho Jpn J Clin Med 28:2465–2468, 1970

    Google Scholar 

  5. Karim SMM, Carter DC, Bhana D, Adaikan Ganesan P: Inhibition of basal and pentagastrin induced gastric acid secretion in man with prostaglandin 16,16-dimethyl PGE2 methyl ester. Int Res Commun Syst 1:24, 1973

    Google Scholar 

  6. Robert A: Antisecretory antiulcer, cytoprotective and diarrheogenic properties of the prostaglandins. Adv Prostaglandin Thromboxane Res 2:507–520, 1976

    Google Scholar 

  7. Bolton JP, Cohen MM: Permeability effects of the E2 prost glandins on canine gastric mucosa. Gastroenterology 70:865, 1976

    Google Scholar 

  8. Whiteman P: The quantitative determination of glycoaminoglycans in urine with Alcian blue 8GX. Biochem J 121:251–257, 1973

    Google Scholar 

  9. Corne SJ, Morrissey SM, Woods RJ: A method for quantitative estimation of gastric barrier mucus. J Physiol (London) 242:116–117, 1974

    Google Scholar 

  10. Piper DW, Whitecross D, Leonard P, Clarke A: Alcian blue binding properties of gastric juice. Gastroenterology 59:534–538, 1970

    Google Scholar 

  11. Cohen MM, Bolton JP: Unpublished data.

  12. MacDonald AS, Steel BJ, Bottomley MC: Treatment of stress-induced upper gastrointestinal haemorrhage with metiamide. Lancet 1:68–70, 1976

    Google Scholar 

  13. Fung WP, Karim SMM, Tye CY: Effect of 15(R)-15-methyl prostaglandin E2 methyl ester on the healing of gastric ulcers. Controlled endoscopic study. Lancet 2:10–12, 1974

    Google Scholar 

  14. Celestin LR: Treatment of duodenal ulcer by metiamide: A multicentre trial. Lancet 2:779–781, 1975

    Google Scholar 

  15. Pounder RE, Williams JG, Milton-Thompson GJ, Misiewicz JJ: Relief of duodenal ulcer symptoms by oral metiamide. Br Med J 2:307–309, 1975

    Google Scholar 

  16. Cohen MM, Pollett JM. Prostaglandin E2 prevents aspirin and indomethacin damage to human gastric mucosa. Surg Forum 27:400–401, 1976

    Google Scholar 

  17. Dean ACB: Protective effect of carbenoxolone in drug induced lesions of the stomach. Carbenoxolone Sodium: A Symposium, JM Robson, FM Sulivan (eds). London, Butterworths, 1968, pp 33–39

    Google Scholar 

  18. Fung WP, Lee SK, Karim SMM: Effect of prostaglandin 15(R)-15-methyl-E2-methyl ester on the gastric mucosa in patients with peptic ulceration—an endoscopic and histological study. Prostaglandins 5:465–472, 1974

    Google Scholar 

  19. O'Brien PE, Carter DC: Effect of gastric secretory inhibitors on the gastric mucosal barrier. Gut 16:437–442, 1975

    Google Scholar 

  20. Bolton JP, Cohen MM: 16,16-dimethyl prostaglandin E2 is not a barrier breaker. Surg Forum 28:363–366, 1977

    Google Scholar 

  21. Hollander F: The electrolyte pattern of gastric mucinous secretions: Its implication for cystic fibrosis. Ann NY Acad Sci 106:757–766, 1963

    Google Scholar 

  22. Altamirano M: Alkaline secretions produced by intra-arterial acetylcholine. J Physiol (London) 168:787–803, 1963

    Google Scholar 

  23. Fromm D, Fuhro R: Active bicarbonate secretion by mammalian antrum. Surg Forum 27:437–440, 1976

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Support by: grant MA-5316 from the Medical Research Council, and the Upjohn Company

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolton, J.P., Palmer, D. & Cohen, M.M. Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Digest Dis Sci 23, 359–364 (1978). https://doi.org/10.1007/BF01072421

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01072421

Keywords

Navigation